Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-16

FDA Approved: TIAGABINE HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original ANDA for tiagabine hydrochloride from Novadoz Pharmaceuticals LLC, granting a generic version for the treatment of partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiagabine hydrochloride (tiagabine hydrochloride)

Snippet

ORIG AP for TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)